Supporting fundraising & communications

2024

CASE STUDY

BIOTECHNOLOGY

Trusted by:

... and many others

THE GOAL

CUSTOMER'S Profile

Launch the program. As a new brand, Ambros needed to build credibility through a consistent brand identity across all assets. Ambros' ultimate goal is to streamline its fundraising and licensing efforts.

Ambros Therapeutics is a clinical-stage biotechnology company focused on the development of innovative and transformative medicine against complex regional pain syndrome type 1 (CRPS-1), a devastating rare metabolic bone disease that causes severe pain following trauma to the bone or an injury.

Brand Identity Complex:

Logo
templates
color palettes
website
pitch deck
3D MoA video.

THE DELIVERABLES

meetings

Communication with client is essential for us. To listen to them and provide with the best result

rounds

Four feedback rounds on the production stage

Claryfiying objectives, requirements, and references

Final Website Version

Final Pitch Deck Design

Final Logo and Brand Design

weeks

Duration from the first kick-off meeting to the final delivery of all the materials

Timeline and Process

Providing final pitch deck

Presentation of the pitch deck, implementation of changes according to revisions

First draft of the MoA video

WEEK 1

WEEK 3

WEEK 6

WEEK 7

WEEK 8

Brand Identity Development

The Ambros Therapeutics logo embodies strength, dynamism, and innovation. Its key element is the wave ‒ a symbol of power, energy, and continuous progress.

We carefully chose the favicon, the wave itself, the typography and the color scheme, so that Ambros would be able to include the logo everywhere: from the office to the website.

Visualizing complex science

Ambros's technology is highly innovative and cannot be conveyed in words alone.

Therefore, we transformed this intricate concept into clear, engaging visuals that both served fundraising purposes and an explanatory role during the clinical trials.

Ambros's Website

We developed Ambros's website from scratch.

After finalizing the logo and general brand identity (color palette, templates, fonts), we developed the website. The website consists of 8 pages and took 3 weeks to complete.

Ambros's Fundraising Results

On Decemer 16th 2025,

"Ambros Therapeutics launched publicly with a $125 million Series A financing co-led by RA Capital Management and Patient Square Capital‘s strategic health care investment arm Enavate Sciences. The company licensed the rights to neridronate, which is used to treat Complex Regional Pain Syndrome."

Source: Crunchbase

Danielle Spangler

Ambros Therapeutics

Feedback

Thanks to the newly developed comms assets, BiPER Therapeutics received the Boston Biotech Summit's Vice Champion Award and was nominated for the Best Startup category by The Galien Foundation.

I personally wanted to thank you for all your hard work and kindness. You were so patient and professional. I want to sincerely thank you and your team for the work you delivered. The website, brand, and visual assets have served us well, and we've appreciated the partnership.